QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session

Rhea-AI Summary

QHSLab (OTCQB: USAQ) provided an unaudited financial and operational update ahead of a January 6, 2026 investor session. For the nine months ended September 30, 2025 the company reported $1.99 million in revenue, a 32% year-over-year increase, with $1.32 million gross profit and an approximate 66% gross margin. Net operating income before interest was $95,738.

At December 31, 2025 the company reported approximately $630,000 cash. Convertible debt was reduced from about $1.4 million to $20,000, which the company says should lower annual interest expense by more than $250,000. Outstanding shares total 13,418,899 with a public float of about 2,429,525 and ~2,301,565 restricted shares subject to Rule 144.

Management said it exited 2025 in a cash-flow-positive operating position and expects to report net income after interest, amortization, and depreciation for 2025, subject to year-end close and audit.

Positive

• Revenue +32% YoY to $1.99M (9 months ended Sept 30, 2025)
• Gross margin approximately 66% for nine months
• Convertible debt reduced from $1.4M to $20,000
• Expected annual interest expense reduction of >$250,000

Negative

• Cash at bank approximately $630,000 as of Dec 31, 2025
• Net operating income before interest only $95,738 (9 months)
• Public trading float approx 2.43M shares (limited liquidity)
• Approximately 2.30M restricted shares subject to Rule 144

News Market Reaction – USAQ

-9.62%

1 alert

-9.62% News Effect

On the day this news was published, USAQ declined 9.62%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Unaudited update reflects revenue growth, positive operating income, removal of convertible debt, and improved cash flow profile entering 2026.

Company reports $1.99 million in revenue for the nine months ended September 30, 2025, up 32% YoY, eliminates convertible debt, and ends the year with approximately $630,000 in cash.

West Palm Beach, FL, Jan. 06, 2026 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health infrastructure company focused on supporting primary care practices, today provided an unaudited business and financial update in advance of a scheduled investor discussion today.

Unaudited Financial Highlights

The following financial information is unaudited and based on the Company’s internal records and most recent publicly reported filings.
• For the nine months ended September 30, 2025, the Company reported revenue of $1.99 million, representing a 32 percent increase year over year.
• Gross profit for the nine months was $1.32 million, reflecting a gross margin of approximately 66 percent.
• Net operating income before interest was $95,738.
• Cash at bank as of December 31, 2025 was approximately $630,000.

Balance Sheet and Capital Structure Update

During the fourth quarter of 2025, the Company continued to increase its revenue run rate and completed actions to simplify its balance sheet and improve its long-term capital structure.
• Outstanding convertible debt has been practically eliminated, reduced from approximately $1.4 million to $20,000.
• The elimination of convertible debt is expected to reduce annual interest expense by more than $250,000 on a forward-looking basis.
• Management believes the Company exited 2025 in a cash-flow-positive operating position.

Capital Structure and Public Float

As of the date of this release, the Company has 13,418,899 shares of common stock outstanding, of which approximately 2,429,525 shares constitute the public trading float.

Included in the outstanding shares are approximately 2,301,565 restricted common shares issued in connection with recent debt conversions, equity financings, and preferred share dividend payments. These shares are subject to Rule 144 restrictions and generally may not be resold into the public market until the applicable six-month holding period has elapsed and other Rule 144 conditions are satisfied.

OTC Markets reflects the Company’s current outstanding share count and public float information consistent with these disclosures.

Operational Outlook

Based on current operating performance and the reduction in interest expense, management believes the Company is positioned for improved operating leverage entering 2026 and expects to report net income after interest, amortization, and depreciation for the year ended December 31, 2025, subject to completion of year-end financial close and audit procedures.

This disclosure is provided to support transparency ahead of upcoming investor discussions and does not constitute guidance. All financial information presented herein is unaudited.

About QHSLab

QHSLab, Inc. (OTCQB: USAQ) is a digital health infrastructure company providing preventive screening, assessment, and workflow solutions for primary care practices. Its platform enables care that occurs outside the exam room, including screening, monitoring, education, and follow-up, to be delivered in a scalable, documented, and reimbursable manner across multiple underdiagnosed conditions.

Forward-Looking Statements

Certain matters discussed in this press release are ‘forward-looking statements’ intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company’s statements regarding trends in the marketplace, future revenues, future products, and potential future results and acquisitions are examples of such forward-looking statements. Forward-looking statements are generally identified by words such as ‘may,’ ‘could,’ ‘believes,’ ‘estimates,’ ‘targets,’ ‘expects,’ or ‘intends,’ and other similar words that express risks and uncertainties. These statements are subject to numerous risks and uncertainties, including, but not limited to, the timing of the introduction of new products, the inherent discrepancy in actual results from estimates, projections, and forecasts made by management, regulatory delays, changes in government funding and budgets, and other factors, including general economic conditions, not within the Company’s control. The factors discussed herein and expressed from time to time in the Company’s filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release. The Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Investor Relations Contact:

Olivia Giamanco
QHSLab, Inc.
(929) 379-6503
ir@usaqcorp.com
https://twitter.com/QHSLabInc

FAQ

What revenue did QHSLab (USAQ) report for the nine months ended Sept 30, 2025?

QHSLab reported $1.99 million in revenue for the nine months ended Sept 30, 2025, a 32% increase year over year.

How much cash did QHSLab (USAQ) have at year-end Dec 31, 2025?

The company reported approximately $630,000 in cash at bank as of Dec 31, 2025.

How much convertible debt did QHSLab (USAQ) eliminate in Q4 2025?

Convertible debt was reduced from about $1.4 million to approximately $20,000.

What interest savings did QHSLab (USAQ) expect from debt reduction?

The company expects to reduce annual interest expense by more than $250,000 on a forward-looking basis.

How many shares outstanding and what is the public float for USAQ?

QHSLab has 13,418,899 shares outstanding with a public float of about 2,429,525 shares.

Did QHSLab (USAQ) report profitability for 2025?

Management expects to report net income after interest, amortization, and depreciation for 2025, subject to year-end close and audit procedures.